基本介紹
- 中文名：蔣亞文
- 國籍：中華人民共和國
- 民族：漢
- 職業：副教授
- 畢業院校：南加州大學
- 專業：衛生經濟學；藥物經濟學
教育科研,代表性論文,
工作經歷
2019/04至今 中山大學公共衛生學院（深圳），副教授
2016/03-2019/04 美國安進公司 (Amgen Inc.) ，全球衛生經濟學經理
2012/05-2016/03 南加州大學Schaeffer衛生政策與經濟研究中心，研究助理
教育經歷
2012/08-2016/03 南加州大學，藥物與衛生經濟系，哲學博士
2010/08-2012/05 南加州大學，藥物經濟與政策系，理學碩士
2006/09-2010/07 暨南大學，藥學、金融，理學學士及經濟學學士
教育科研
中山大學百人計畫，2019。近五年以第一作者或唯一通訊作者在PharmacoEconomics、Osteoporosis International、Journal of Managed Care & Specialty Pharmacy、CNS Drugs等SCI/SSCI期刊共發表多篇論文。
研究方向：
- 衛生經濟與政策、醫療保險
- 藥物經濟與結果研究、真實世界數據、藥物流行病學
- 套用微觀計量經濟
- 與健康相關的行為經濟學及個體經濟學
代表性論文
- Jiang, Y.* & Ni, W. Economic Evaluation of the 2016 Chinese Guideline and Alternative Risk Thresholdsof Initiating Statin Therapy for the Management of Atherosclerotic Cardiovascular Disease. (2019). PharmacoEconomics.doi: 10.1007/s40273-019-00791-8.
- Jiang, Y.* & Ni, W. Factors Related to the Comparative Effectiveness of Clozapine in Patients with Schizophrenia. (2019). Journal of Comparative Effectiveness Research. Feb;8(3):179-185. doi: 10.2217/cer-2018-0096.
- Jiang, Y.* & Ni, W. Estimates of Age-specific Diabetes Incidence among Men and Women in China Using Secondary Data Analysis. (2019). Diabetic Medicine. Mar;36(3):388-389. doi: 10.1111/dme.13821. (research letter)
- Jiang, Y.*, McCombs, J. S., & Park, S. H. A Retrospective Cohort Study of Acute Kidney Injury Risk Associated with Antipsychotics. CNS drugs 31.4 (2017): 319-326. doi: 10.1007/s40263-017-0421-4
- Ni, W. & Jiang, Y.* Evaluation on the Cost-effective Threshold of Osteoporosis Treatment on Elderly Women in China Using Discrete Event Simulation Model. Osteoporosis International. 2017 Feb;28(2):529-538. doi: 10.1007/s00198-016-3751-z.
- Jiang, Y.* & Ni, W. Expected Lifetime Numbers, Risks, and Burden of Osteoporotic Fractures for 50-Year Old Chinese Women— a Discrete Event Simulation Incorporating FRAX. Journal of Bone and Mineral Metabolism. 2016 Nov;34(6):714-722. doi: 10.1007/s00774-015-0724-9.
- Jiang, Y.* & Ni, W. Healthcare Utilization and Treatment Persistence Associated with Oral Paliperidone and Lurasidone in Schizophrenia Treatment. Journal of Managed Care Pharmacy. 2015 Sep;21(9):780-92. doi: 10.18553/jmcp.2015.21.9.780.
- Jiang, Y.* & Ni, W. Estimating the Impact of Adherence to and Persistence with Atypical Antipsychotic Therapy on Health Care Costs and Risk of Hospitalization. Pharmacotherapy. 35.9 (2015): 813-822. doi: 10.1002/phar.1634.
- Jiang, Y.*, Ni, W., McGinnis, J. Comparison of Health Services Use Associated with Ziprasidone and Olanzapine among Schizophrenia and Bipolar Disorder Patients in the USA. Clin Drug Investig: 34.7 (2014): 491-499. doi:10.1007/s40261-014-0202-5.
- Jiang, Y.* & McCombs, J. Improving Model Specifications When Estimating Treatment Effects across Alternative Medical Interventions. Open Journal of Statistics, 4.10 (2014): 857. doi: 10.4236/ojs.2014.410081.
- Trief, P.*, Jiang, Y., Beck, R., Huckfeldt, P., Knight, T., Miller, K., Weinstock, R. Adults with Type 1 Diabetes: Partner Relationships and Outcomes. Journal of Health Psychology. 22.4 (2017): 446-456. doi:10.1177/1359105315605654.
- Thomas, K.*, Jiang, Y., McCombs, J. Clozapine Revisited: Impact of Clozapine versus Olanzapine on Health Care Use by Medicaid Schizophrenia Patients. Annals of Clinical Psychiatry 27.2 (2015): 90-99.
- He,X.,Wu,J.*,Jiang,Y.,Liu,L.,Ye,W.,Xue,H.,&Montgomery,W.HealthCareResourceUtilizationandDirectMedicalCostsforPatientswithSchizophreniaInitiatingTreatmentwithAtypicalVersusTypicalAntipsychoticsinTianjin,China.BMCHealthServicesResearch,15.1(2015):149.doi:10.1186/s12913-015-0819-y.
- O'Hanlon,C.,Parthan,A.,Kruse,M.,Cartier,S.,Stollenwerk.B.,Jiang,Y.,Caloyeras,J.,Crittenden,B.,Barron,R.*AModelforAssessingtheClinicalandEconomicBenefitsofBone-FormingOsteoporosisAgentsinReducingFracturesinPost-MenopausalWomenatHigh,Near-TermRiskofFragilityFracture.ClinicalTherapeutics39.7(2017):1276-1290.doi:10.1016/j.clinthera.2017.05.348
- 張心科,倪惟一,牛曉麗,蔣亞文,&吳晶*.(2015).保婦康栓和干擾素栓治療低度子宮頸上皮內瘤變的藥物經濟學評價.中國藥物經濟學12(2015):001.
